Rivastigmine
FDA Approved: * January 8, 2008Pharm Company: * WATSON LABS
Category: Alzheimers / Dementia
Rivastigmine (sold under the trade name Exelon among others) is a cholinesterase inhibitor used for the treatment of mild to moderate Alzheimer's disease.[1] The drug can be administered orally or via a transdermal patch; the latter form reduces the prevalence of side effects,[2] which typically include nausea and vomiting.[3] The drug is eliminated through the urine, and appears to have relatively few drug-drug interactions.[3] ... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.Dosage List
![Rivastigmine Watson;3210](/images/NDC/0591-3210.jpg)
Rivastigmine 4.5 mg (As Rivastigmine Tartrate 7.2 mg) Oral Capsule
NDC: 0591-3210
Labeler:
Watson Laboratories, Inc.
![Rivastigmine Watson;3211](/images/NDC/0591-3211.jpg)
Rivastigmine 6 mg (As Rivastigmine Tartrate 9.6 mg) Oral Capsule
NDC: 0591-3211
Labeler:
Watson Laboratories, Inc.
![Rivastigmine SANDOZ;618](/images/NDC/0781-2614.jpg)
Rivastigmine 1.5 mg (As Rivastigmine Tartrate 2.4 mg) Oral Capsule
NDC: 0781-2614
Labeler:
Sandoz Inc
![Rivastigmine SANDOZ;619](/images/NDC/0781-2615.jpg)
![Rivastigmine SANDOZ;620](/images/NDC/0781-2616.jpg)
Rivastigmine 4.5 mg (As Rivastigmine Tartrate 7.2 mg) Oral Capsule
NDC: 0781-2616
Labeler:
Sandoz Inc
![Rivastigmine SANDOZ;625](/images/NDC/0781-2617.jpg)
![Rivastigmine RDY;355](/images/NDC/55111-355.jpg)
Rivastigmine 6 mg (As Rivastigmine Tartrate 9.6 mg) Oral Capsule
NDC: 55111-355
Labeler:
Dr.reddy's Laboratories Limited
![Rivastigmine APO;R1;5](/images/NDC/60429-393.jpg)
![Rivastigmine APO;R3](/images/NDC/60429-394.jpg)
![Rivastigmine APO;R4;5](/images/NDC/60429-395.jpg)